ROYAL BANK OF CANADA - LION BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$21,000
-19.2%
2,828
-26.0%
0.00%
Q4 2016$26,000
+271.4%
3,823
+347.1%
0.00%
Q3 2016$7,000
+16.7%
855
+13.2%
0.00%
Q2 2016$6,000
+100.0%
755
+36.0%
0.00%
Q1 2016$3,000
-40.0%
555
-9.6%
0.00%
Q4 2015$5,000
-58.3%
614
-71.3%
0.00%
Q3 2015$12,000
-50.0%
2,143
-18.8%
0.00%
Q2 2015$24,000
+1100.0%
2,640
+1220.0%
0.00%
Q1 2015$2,0002000.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
Ayer Capital Management, LP 5,604,015$67,865,00099.40%
Avoro Capital Advisors LLC 2,149,907$26,035,0009.99%
ACUTA CAPITAL PARTNERS, LLC 669,196$8,104,0006.83%
Perceptive Advisors 2,714,549$32,873,0002.56%
Opaleye Management Inc. 200,000$2,422,0001.12%
Broadfin Capital, LLC 1,062,419$12,866,0001.00%
QVT Financial LP 1,325,000$16,046,0000.89%
Ghost Tree Capital, LLC 400,000$4,844,0000.87%
Cormorant Asset Management, LP 424,815$5,145,0000.80%
P.A.W. CAPITAL CORP 65,000$787,0000.78%
View complete list of LION BIOTECHNOLOGIES INC shareholders